Recent years have witnessed groundbreaking advances in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://owaingilz557696.bloggosite.com/46497892/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements